Life Science
R&D Prioritization Decision
More than any other factor, the choice of R&D projects defines the future of a life sciences company. Unfortunately all the easy blockbusters are done, and creating value within a project portfolio requires a keen understanding of clinical, market and regulatory risk. High costs and high failure rates keep the stakes high, but DPL can help you discover value with rigor and confidence.